The Behavioral Research Methods Core (BRM) enhances the scientific objectives of the Center's programs by assisting MSKCC investigators with the design, implementation and execution of research involving survey, interview and other behavioral and social sciences research methods. Methodological advances in the behavioral and social sciences are widely recognized as germane to translational research in cancer prevention, early detection, treatment, palliative care, and survivorship, and particularly critical to understanding and reducing disparities in cancer outcomes observed in minority groups. The faculty of the BRM are nationally recognized social and behavioral scientists who provide research design consultation to assist MSKCC investigators. The BRM core facility assists investigators by providing the following specific services and technical support functions: 1) selection, analysis, and interpretation of psychometrically sound assessment tools (self-report surveys, semi-structured interviews and observer ratings) for the measurement of quality of life, health behavior change, and other psychosocial outcomes;2) consultation regarding the development and implementation of research methodologies consistent with """"""""best practices"""""""" in psychosocial and behavioral research in cancer;3) qualitative interview, focus group methodology, and other process evaluation techniques for developing new psychosocial instruments and generating new testable hypotheses;4) training, and troubleshooting with regard to patient interviewing methods, survey data collection and human subjects'issues for research support staff conducting quality of life and behavioral/psychosocial studies;and 5) recruitment and retention of minority populations in clinical trials through active research partnerships with community based clinical care and organizational settings. The BRM core facility maintains an extensive resource library of electronic psychosocial and behavioral measures and research method protocols commonly used in cancer prevention and control research. The BRM core facility supports inter-programmatic scientific exchange and enhances research productivity with shared behavioral research tools and provision of research consultation in behavioral research design.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA008748-47
Application #
8375227
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
2013-12-31
Budget Start
2012-01-09
Budget End
2012-12-31
Support Year
47
Fiscal Year
2012
Total Cost
$45,175
Indirect Cost
Name
Sloan-Kettering Institute for Cancer Research
Department
Type
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10065
Ho, A L (2018) Developing androgen receptor targeting for salivary gland cancers. Ann Oncol 29:792-794
Gupta, Piyush; Migliacci, Jocelyn C; Hay, Ashley et al. (2018) Validation and assessment of discordance of the 8th edition AJCC (American Joint Committee on Cancer) clinical and pathologic staging systems in patients with p16+ oropharyngeal cancer treated with surgery and adjuvant radiation at a single institution. Oral Oncol 83:140-146
Aras, Omer; Pearce, Gillian; Watkins, Adam J et al. (2018) An in-vivo pilot study into the effects of FDG-mNP in cancer in mice. PLoS One 13:e0202482
Chou, Chun; Li, Ming O (2018) Tissue-Resident Lymphocytes Across Innate and Adaptive Lineages. Front Immunol 9:2104
Quezada-Diaz, Felipe; Jimenez-Rodriguez, Rosa M; Pappou, Emmanouil P et al. (2018) Effect of Neoadjuvant Systemic Chemotherapy With or Without Chemoradiation on Bowel Function in Rectal Cancer Patients Treated With Total Mesorectal Excision. J Gastrointest Surg :
Schleicher, Stephen M; Bach, Peter B; Matsoukas, Konstantina et al. (2018) Medication overuse in oncology: current trends and future implications for patients and society. Lancet Oncol 19:e200-e208
Moore, Amanda R; Ran, Leili; Guan, Youxin et al. (2018) GNA11 Q209L Mouse Model Reveals RasGRP3 as an Essential Signaling Node in Uveal Melanoma. Cell Rep 22:2455-2468
Davis, Mellar P; Pasternak, Gavril; Behm, Bertrand (2018) Treating Chronic Pain: An Overview of Clinical Studies Centered on the Buprenorphine Option. Drugs 78:1211-1228
Suzawa, Ken; Offin, Michael; Lu, Daniel et al. (2018) Activation of KRAS Mediates Resistance to Targeted Therapy in MET Exon 14-mutant Non-small Cell Lung Cancer. Clin Cancer Res :
Horvat, Joao V; Durando, Manuela; Milans, Soledad et al. (2018) Apparent diffusion coefficient mapping using diffusion-weighted MRI: impact of background parenchymal enhancement, amount of fibroglandular tissue and menopausal status on breast cancer diagnosis. Eur Radiol 28:2516-2524

Showing the most recent 10 out of 8799 publications